Analysis of genomic downsizing on the basis of region-of-difference polymorphism profiling of Mycobacterium tuberculosis patient isolates reveals geographic partitioning
- PMID: 16333085
- PMCID: PMC1317167
- DOI: 10.1128/JCM.43.12.5978-5982.2005
Analysis of genomic downsizing on the basis of region-of-difference polymorphism profiling of Mycobacterium tuberculosis patient isolates reveals geographic partitioning
Abstract
Mycobacterium tuberculosis, the etiological agent of tuberculosis, has lost many coding and noncoding regions in its genome during the course of evolution. We performed region-of-difference (RD) analysis using PCR-based genotyping of 131 M. tuberculosis clinical isolates obtained from four different countries, namely, India, Peru, Libya, and Angola. Our studies revealed that RD patterns are often distinct for strains circulating in specific geographical regions and can be used to trace the descent and spread of an isolate from its original reservoir. We describe our findings, which show that no single isolate from the four countries (n = 131) had all the 15 RDs either deleted or retained. Tuberculosis-specific deletion 1 (TbD1) was found to be conserved in 23% of the Indian isolates, indicating their possible ancient origin. RD9 was the most conserved region, RD11 was predominantly deleted, and RD6 was the most variable among the isolates in our collection irrespective of their geographic region. In contrast to earlier reports, our results demonstrate that the deletion of RD1 does not correlate with a decrease in the virulence potential of M. tuberculosis, as Indian isolates (n = 30) examined by us were from diseased individuals and yet had lost the RD1 region. Our results further illustrated that the intactness of the RD5 region may be associated with increased virulence of the organism. This study highlights that the RDs in M. tuberculosis genomes are geographically distributed and specific and may possibly be associated with virulence spectrum.
Figures
Similar articles
-
Identification of moaA3 gene in patient isolates of Mycobacterium tuberculosis in Kerala, which is absent in M. tuberculosis H37Rv and H37Ra.BMC Infect Dis. 2005 Oct 4;5:81. doi: 10.1186/1471-2334-5-81. BMC Infect Dis. 2005. PMID: 16202156 Free PMC article.
-
Characterization of predominant Mycobacterium tuberculosis strains from different subpopulations of India.Infect Genet Evol. 2009 Sep;9(5):832-9. doi: 10.1016/j.meegid.2009.05.008. Epub 2009 May 20. Infect Genet Evol. 2009. PMID: 19463970
-
Genetic characterization of Mycobacterium tuberculosis clinical isolates with deletions in the plcA-plcB-plcC locus.Tuberculosis (Edinb). 2007 Jan;87(1):21-9. doi: 10.1016/j.tube.2006.01.023. Epub 2006 May 15. Tuberculosis (Edinb). 2007. PMID: 16704934
-
Role of M. tuberculosis RD-1 region encoded secretory proteins in protective response and virulence.Tuberculosis (Edinb). 2008 Nov;88(6):510-7. doi: 10.1016/j.tube.2008.05.002. Epub 2008 Jul 21. Tuberculosis (Edinb). 2008. PMID: 18640874 Review.
-
[New era in molecular epidemiology of tuberculosis in Japan].Kekkaku. 2006 Nov;81(11):693-707. Kekkaku. 2006. PMID: 17154049 Review. Japanese.
Cited by
-
Identification of RD5-encoded Mycobacterium tuberculosis proteins as B-cell antigens used for serodiagnosis of tuberculosis.Clin Dev Immunol. 2012;2012:738043. doi: 10.1155/2012/738043. Epub 2012 Jun 4. Clin Dev Immunol. 2012. PMID: 22701501 Free PMC article.
-
Low frequency of moaA3 gene among the clinical isolates of Mycobacterium tuberculosis from Tamil Nadu and Pondicherry--south eastern coastal states of India.BMC Infect Dis. 2009 Jul 25;9:114. doi: 10.1186/1471-2334-9-114. BMC Infect Dis. 2009. PMID: 19630991 Free PMC article.
-
Comparative analyses of nonpathogenic, opportunistic, and totally pathogenic mycobacteria reveal genomic and biochemical variabilities and highlight the survival attributes of Mycobacterium tuberculosis.mBio. 2014 Nov 4;5(6):e02020. doi: 10.1128/mBio.02020-14. mBio. 2014. PMID: 25370496 Free PMC article.
-
Mycobacterium tuberculosis Methyltransferase Rv1515c Can Suppress Host Defense Mechanisms by Modulating Immune Functions Utilizing a Multipronged Mechanism.Front Mol Biosci. 2022 Jun 24;9:906387. doi: 10.3389/fmolb.2022.906387. eCollection 2022. Front Mol Biosci. 2022. PMID: 35813825 Free PMC article.
-
Molecular analysis of a leprosy immunotherapeutic bacillus provides insights into Mycobacterium evolution.PLoS One. 2007 Oct 3;2(10):e968. doi: 10.1371/journal.pone.0000968. PLoS One. 2007. PMID: 17912347 Free PMC article.
References
-
- Ahmed, N., L. Caviedes, M. Alam, K. R. Rao, V. Sangal, P. Sheen, R. H. Gilman, and S. H. Hasnain. 2003. Distinctiveness of Mycobacterium tuberculosis genotypes from human immunodeficiency virus type 1-seropositive and -seronegative patients in Lima, Peru. J. Clin. Microbiol. 41:1712-1716. - PMC - PubMed
-
- Ahmed, N., M. Alam, K. R. Rao, F. Kauser, N. A. Kumar, N. N. Qazi, V. Sangal, V. D. Sharma, R. Das, V. M. Katoch, K. J. Murthy, S. Suneetha, S. K. Sharma, L. A. Sechi, R. H. Gilman, and S. E. Hasnain. 2004. Molecular genotyping of a large, multicentric collection of tubercle bacilli indicates geographical partitioning of strain variation and has implications for global epidemiology of Mycobacterium tuberculosis. J. Clin. Microbiol. 42:3240-3247. - PMC - PubMed
-
- Behr, M. A., M. A. Wilson, W. P. Gill, H. Salamon, G. K. Schoolnik, S. Rane, and P. M. Small. 1999. Comparative genomics of BCG vaccines by whole-genome DNA microarray. Science 284:1520-1523. - PubMed
-
- Brosch, R., S. V. Gordon, M. Marmiesse, P. Brodin, C. Buchrieser, K. Eiglmeier, T. Garnier, C. Gutierrez, G. Hewinson, K. Kremer, L. M. Par-sons, A. S. Pym, S. Samper, D. van Soolingen, and S. T. Cole. 2002. A new evolutionary scenario for the Mycobacterium tuberculosis complex. Proc. Natl. Acad. Sci. USA 99:3684-3689. - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous